首页> 外文期刊>Nature reviews Cancer >Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
【24h】

Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response

机译:半胱氨酸组织蛋白酶:癌症进展和治疗反应的调节剂

获取原文
获取原文并翻译 | 示例
       

摘要

Cysteine cathepsin protease activity is frequently dysregulated in the context of neoplastic transformation. Increased activity and aberrant localization of proteases within the tumour microenvironment have a potent role in driving cancer progression, proliferation, invasion and metastasis. Recent studies have also uncovered functions for cathepsins in the suppression of the response to therapeutic intervention in various malignancies. However, cathepsins can be either tumour promoting or tumour suppressive depending on the context, which emphasizes the importance of rigorous in vivo analyses to ascertain function. Here, we review the basic research and clinical findings that underlie the roles of cathepsins in cancer, and provide a roadmap for the rational integration of cathepsin-targeting agents into clinical treatment.
机译:在肿瘤转化的背景下,半胱氨酸组织蛋白酶的活性经常失调。肿瘤微环境中蛋白酶的活性增加和异常定位在驱动癌症进展,增殖,侵袭和转移方面具有重要作用。最近的研究还发现组织蛋白酶在抑制各种恶性肿瘤对治疗干预的反应中的功能。然而,组织蛋白酶取决于背景可以是促进肿瘤的或抑制肿瘤的,这强调了严格的体内分析以确定功能的重要性。在此,我们回顾了组织蛋白酶在癌症中的作用基础的基础研究和临床发现,并提供了将组织蛋白酶靶向剂合理整合到临床治疗中的路线图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号